Non-viral gene transfer into murine adipose derived mesenchymal stem cells: A comparative study of different non-viral methods

Gene Therapy and Molecular Biology

Volumn 15, Issue 1, 2013, Pages 164-175

  Bahrambeigi, Vahid ^a,b,c   Ahmadi, Nafiseh ^b   Ghafarizadeh, Ali Asghar ^c   Lotfi, Mehdi ^d   Hashemibeni, Batool ^d   Javanmard, Shaghayegh Haghjooy ^b,d  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Academic Center for Education Culture and Research Markazi Branch   (Iran)

^d ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipose derived mesenchymal stem cells (AD MSCs); Mesenchymal stem cells (MSCs); Nucleofection; Transfection

Indexed keywords

CD105 ANTIBODY; CD24 ANTIBODY; CD34 ANTIBODY; CD45 ANTIBODY; CD73 ANTIBODY; CD90 ANTIBODY; CELL ANTIBODY; ENHANCED GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE DERIVED STEM CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENETIC TRANSFECTION; INTERMETHOD COMPARISON; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; STEM CELL GENE THERAPY; TRANSGENICS;

EID: 84902267414     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Aboody KS, Najbauer J, Danks MK. Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 2008;15(10):739-52.
2. Aluigi M, Fogli M, Curti A, Isidori A, Gruppioni E, Chiodoni C, et al. Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells. Stem Cells. 2006;24(2):454-61.
3. Aslan H, Zilberman Y, Arbeli V, Sheyn D, Matan Y, Liebergall M, et al. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng. 2006;12(4):877-89.
4. Bahrambeigi V, Salehi R, Hashemibeni B, Esfandiari E. Transcriptomic comparison of osteopontin, osteocalcin and core binding factor 1 genes between human adipose derived differentiated osteoblasts and native osteoblasts. Adv Biomed Res. 2012;1:8.
5. Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc Natl Acad Sci US A 2006;103:419-424.
6. Cavarretta IT, Altanerova V, Matuskova M, Kucerova L, Culig Z, Altaner C. Adipose tissue-derived mesenchymal stem cells expressing prodrugconverting enzyme inhibit human prostate tumor growth. Mol Ther. 2009;18(1):223-31.
7. Chalberg TW, Genise HL, Vollrath D, Calos MP. PhiC31 integrase confers genomic integration and long-term transgene expression in rat retina. Invest Ophthalmol Vis Sci 2005;46:2140-2146.
8. Colleoni S, Donofrio G, Lagutina I, Duchi R, Galli C, Lazzari G. Establishment, differentiation, electroporation, viral transduction, and nuclear transfer of bovine and porcine mesenchymal stem cells. Cloning Stem Cells. 2005;7(3):154-66.
9. Distler JH, Jungel A, Kurowska-Stolarska M, Michel BA, Gay RE, Gay S, et al. Nucleofection: a new, highly efficient transfection method for primary human keratinocytes. Exp Dermatol. 2005;14(4):315-20.
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-7.
11. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymerbased gene delivery methods. Cytotherapy. 2008;10(8):815-23.
12. Grisendi G, Bussolari R, Cafarelli L, Petak I, Rasini V, Veronesi E, et al. Adiposederived mesenchymal stem cells as stable source of tumor necrosis factorrelated apoptosis-inducing ligand delivery for cancer therapy. Cancer Res. 2010;70(9):3718-29.
13. Haleem-Smith H, Derfoul A, Okafor C, Tuli R, Olsen D, Hall DJ, et al. Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol. 2005;30(1):9-20.
14. Hass R, Kasper C, Bohm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12.
15. Ishikawa Y, Tanaka N, Murakami K, Uchiyama T, Kumaki S, Tsuchiya S, et al. Phage phiC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines. J Gene Med 2006;8:646-653.
16. Keravala A, Ormerod BK, Palmer TD, Calos MP. Long-term transgene expression in mouse neural progenitor cells modified with phiC31 integrase. J Neurosci Methods. 2008;173(2):299-305.
17. Keravala A, Portlock JL, Nash JA, Vitrant DG, Robbins PD, Calos MP. PhiC31 integrase mediates integration in cultured synovial cells and enhances gene expression in rabbit joints. J Gene Med 2006;8:1008-1017.
18. Kucerova L, Matuskova M, Pastorakova A, Tyciakova S, Jakubikova J, Bohovic R, et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med. 2008;10(10):1071-82.
19. Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, et al. Mesenchymal Stem Cells Overexpressing IFN-beta Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model. Cancer Microenviron. 2010;3(1):83-95.
20. Madeira C, Mendes RD, Ribeiro SC, Boura JS, Aires-Barros MR, da Silva CL, et al. Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J Biomed Biotechnol. 2010;2010:735349.
21. Nakashima S, Matsuyama Y, Nitta A, Sakai Y, Ishiguro N. Highly efficient transfection of human marrow stromal cells by nucleofection. Transplant Proc. 2005;37(5):2290-2.
22. Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Sitespecific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 2002;20:1124-1128.
23. Ortiz-Urda S, Thyagarajan B, Keene DR, Lin Q, Fang M, Calos MP, Khavari PA. Stable nonviral geneticcorrection of inherited human skin disease. Nat Med 2002;8:1166-1170.
24. Quenneville SP, Chapdelaine P, Rousseau J, Beaulieu J, Caron NJ, Skuk D, et al. Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther 2004;10:679-687.
25. Portlock JL, Keravala A, Bertoni C, Lee S, Rando TA, Calos MP. Long-term increase in mVEGF164 in mouse hindlimb muscle mediated by phage phiC31 integrase after nonviral DNA delivery. Hum Gene Ther 2006;17:871-876.
26. Rountree CB. Stem cells in drug discovery, regenerative medicine and cancer. Genome Med. 2011;3(3):15.
27. Scheibe F, Gladow N, Mergenthaler P, Tucker AH, Meisel A, Prockop DJ, et al. Nonviral gene delivery of erythropoietin by mesenchymal stromal cells. Gene Ther. 2011;19(5):550-60.
28. Van Damme A, Vanden Driessche T, Collen D, Chuah MK. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther. 2002;2(2):195-209.
29. Yagi H, Soto-Gutierrez A, Parekkadan B, Kitagawa Y, Tompkins RG, Kobayashi N, et al. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant. 2010;19(6):667-79.
30. Zaragosi LE, Billon N, Ailhaud G, Dani C. Nucleofection is a valuable transfection method for transient and stable transgene expression in adipose tissuederived stem cells. Stem Cells. 2007;25(3):790-7.
31. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct. 2008;26(6):664-75.
32. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13(12):4279-95.